Skip to main content
Ganesh Benzoplast Ltd. logo

Ganesh Benzoplast Ltd. — Investor Relations & Filings

Ticker · GANESHBE ISIN · INE388A01029 LEI · 335800ADMLACZ4KJML55 BSE.NS Transportation and storage
Filings indexed 926 across all filing types
Latest filing 2024-11-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS GANESHBE

About Ganesh Benzoplast Ltd.

https://www.ganeshbenzoplast.com/

Ganesh Benzoplast Ltd. operates as an independent liquid storage tank provider and a manufacturer of specialty chemicals. The company manages a comprehensive network of bulk liquid storage terminals at major ports, offering infrastructure for the handling and storage of liquid chemicals, petroleum products, and edible oils. Its chemical manufacturing division focuses on the production of food preservatives, specifically sodium benzoate, alongside lubricant additives and plasticizers. The organization provides critical logistics support through its storage facilities and supplies chemical components to the food, automotive, and industrial sectors. By integrating port-based storage solutions with chemical production, the company maintains a significant presence in the midstream logistics and specialty chemical supply chains.

Recent filings

Filing Released Lang Actions
Financial results
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from the Board of Directors dated November 14, 2024, regarding the approval of standalone and consolidated unaudited financial results for the quarter and half year ended September 30, 2024. It includes a limited review report by the statutory auditors, which is typical for interim financial results. The document contains substantive financial data such as income, expenses, profit before tax, tax expenses, and net profit after tax for the quarter and half year periods. The presence of unaudited financial results and a limited review report aligns with the characteristics of an Interim / Quarterly Report (IR). The document is not merely an announcement of a report but contains the actual financial data and auditor's review, so it is not a Report Publication Announcement (RPA) or Regulatory Filing (RNS). Therefore, the correct classification is Interim / Quarterly Report (IR). H1 2025
2024-11-14 English
Disclosure under Regulation 30
Regulatory Filings Classification · 95% confidence The document is a formal disclosure made by Ganesh Benzoplast Limited to stock exchanges regarding a warning letter received from the National Stock Exchange (NSE) about a compliance issue related to the disclosure of the company's PAN in public documents. The content includes the warning letter itself and the company's response, emphasizing regulatory compliance and corrective measures. There are no financial statements, earnings data, or detailed management analysis present. The document is a regulatory announcement about a compliance matter under SEBI Listing Regulations, not a financial report or management report. It fits the category of Regulatory Filings (RNS) as it is a general regulatory announcement and compliance disclosure that does not fit into more specific categories like Annual Report, Earnings Release, or Management Reports.
2024-11-08 English
General Updates
Regulatory Filings Classification · 95% confidence The document is a formal disclosure made by Ganesh Benzoplast Limited to stock exchanges regarding a warning letter received from the National Stock Exchange (NSE) about a compliance issue related to the disclosure of the company's PAN in public documents. The letter includes details of the warning, the nature of the violation, and the company's commitment to corrective measures. There are no financial statements, earnings data, or detailed management analysis present. The document is a regulatory announcement about a compliance matter under SEBI Listing Regulations, not a financial report or management discussion. It fits the description of a Regulatory Filing (RNS) as it is a general regulatory announcement and compliance disclosure that does not fit into more specific categories like Annual Report, Earnings Release, or Management Reports.
2024-11-08 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-11-06 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a formal letter addressed to stock exchanges and corporate services departments, notifying them of an upcoming Board Meeting scheduled for November 14, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (which pertains to Board Meeting intimation) and Regulation 33 (financial results disclosure). The document itself does not contain any financial data or results but is an announcement of the Board Meeting where such results will be approved. The document length is short (1658 characters), and it serves as an intimation rather than the actual financial report or results. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and notification of a Board Meeting, not the financial report itself or a management report.
2024-11-06 English
GANESH BENZOPLAST LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 ,inter alia, to consider and approve standalone and consolidated ....
Regulatory Filings Classification · 95% confidence The document is a formal notice informing stock exchanges about an upcoming Board Meeting scheduled for November 14, 2024. The purpose of the meeting is to consider and approve the unaudited financial results for the quarter and half year ended September 30, 2024. The document references compliance with SEBI Listing Regulations, specifically Regulation 29 (which pertains to Board Meeting intimation) and Regulation 33 (financial results disclosure). The document itself does not contain any financial data or results but is an announcement of the meeting where such results will be approved. The document length is short (1665 characters), and it serves as an intimation rather than the actual financial report or results. Therefore, it fits the category of a Regulatory Filing (RNS) as a general regulatory announcement and compliance document rather than an Interim Report (IR) or Earnings Release (ER).
2024-11-06 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.